The International Journal of Tuberculosis and Lung Disease

Measuring asthma, respiratory symptoms, and changes over time [Editorial]
pp. 1395-1395(1)
Author: Mannino, David M.

The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfalls [Unresolved Issues]
pp. 1396-1400(5)
Author: Sterling, T. R.

Indoor air pollution and airway disease [State of the Art]
pp. 1401-1415(15)
Authors: Viegi, G.; Simoni, M.; Scognamiglio, A.; Baldacci, S.; Pistelli, F.; Carrozzi, L.; Annesi-Maesano, I.

Trends in symptoms of obstructive lung disease in Norway
pp. 1416-1422(7)
Authors: Brøgger, J.; Bakke, P.; Eide, G. E.; Johansen, B.; Andersen, A. R.; Gulsvik, A.

Smoking-related diseases: the importance of COPD
pp. 1423-1428(6)
Authors: Zaher, C.; Halbert, R.; Dubois, R.; George, D.; Nonikov, D.

The effects of age, death period and birth cohort on asthma mortality rates in Australia
pp. 1429-1436(8)
Authors: Dobbin, C. J.; Miller, J.; van der Hoek, R.; Baker, D. F.; Cumming, R.; Marks, G. B.

Can BCG-vaccinated children be included in tuberculin surveys to estimate the annual risk of tuberculous infection in India?
pp. 1437-1442(6)
Authors: Chadha, V. K.; Jagannatha, P. S.; Kumar, P.

Physician attitudes regarding bacille Calmette-Guérin vaccination and treatment of latent tuberculosis infection
pp. 1443-1447(5)
Authors: Salazar-Schicchi, J.; Jedlovsky, V.; Ajayi, A.; Colson, P. W.; Hirsch-Moverman, Y.; El-Sadr, W.

Molecular epidemiology of drug-resistant Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Poland: a 1-year study
pp. 1448-1457(10)
Authors: Sajduda, A.; Brzostek, A.; Popławska, M.; Rastogi, N.; Sola, C.; Augustynowicz-Kopeć, E.; Zwolska, Z.; Dziadek, J.; Portaels, F.

Molecular epidemiology of tuberculosis in the Bata and Malabo districts of Equatorial Guinea
pp. 1458-1463(6)
Authors: Tudó, G.; González-Martín, J.; Obama, R.; Rodríguez, J. M.; Franco, J. R.; Espasa, M.; Simarro, P. P.; Escaramís, G.; Ascaso, C.; García, A.; Jiménez De Anta, M. T.

SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa
pp. 1464-1471(8)
Authors: Hoal, E. G.; Lewis, L-A.; Jamieson, S. E.; Tanzer, F.; Rossouw, M.; Victor, T.; Hillerman, R.; Beyers, N.; Blackwell, J. M.; Van Helden, P. D.

Tuberculosis at Edendale Hospital in Pietermaritzburg, KwaZulu Natal, South Africa
pp. 1472-1478(7)
Authors: Alvarez, G. G.; Thembela, B. L.; Muller, F. J.; Clinch, J.; Singhal, N.; Cameron, D. W.

Access and adhering to tuberculosis treatment: barriers faced by patients and communities in Burkina Faso
pp. 1479-1483(5)
Authors: Sanou, A.; Dembele, M.; Theobald, S.; Macq, J.

Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon
pp. 1484-1491(8)
Authors: Baldwin, M. R.; Yori, P. P.; Ford, C.; Moore, D. A. J.; Gilman, R. H.; Vidal, C.; Ticona, E.; Evans, C. A.

Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong
pp. 1492-1498(7)
Authors: Chang, K-C.; Leung, C-C.; Tam, C-M.

The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity
pp. 1499-1505(7)
Authors: Fernández-Villar, A.; Sopeña, B.; Fernández-Villar, J.; Vázquez-Gallardo, R.; Ulloa, F.; Leiro, V.; Mosteiro, M.; Piñeiro, L.

Interpreting and reporting results [Research Methods]
pp. 1506-1509(4)
Authors: Enarson, D. A.; Kennedy, S. M.; Miller, D. L.; Bakke, P.

Correspondence
pp. 1510-1513(4)

Errata
pp. 1513-1513(1)